🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Hafuu Seli Xiqqaa › Illinois › Chicago

Qorannoo klinikaalii Kansarii Hafuu Seli Xiqqaa Chicago, IL keessatti

Qorannoo 13 Kansarii Hafuu Seli Xiqqaa f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • The University of Chicago, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07454642

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University of Chicago Medical Center /ID# 280149, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07365241

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Northwestern University Feinberg School of Medicine, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05983432

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Chicago ( Site 1108), Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06780137

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07057791

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Rush MD Anderson Cancer Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06203210

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Namoota walitti qabaa jiraSadarkaa 1
  • University of Illinois Chicago, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT06598306

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of Illinois Chicago, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT07149363

A Study of LY4175408 in Participants With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • The University of Chicago Medical Center (UCMC), Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT07046923

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of Illinois Cancer Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Elb-2026 · NCT04919382

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern University, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Bit-2026 · NCT06769126

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Namoota walitti qabaa jiraSadarkaa 1/2
  • Jesse Brown VA Medical Center, Chicago, IL, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Bit-2026 · NCT06681220

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Chicago Medicine, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Bit-2026 · NCT05068232

Qorannoo Kansarii Hafuu Seli Xiqqaa magaalota biroo keessatti

Qorannoo biroo Chicago keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.